Skip to content

LONA LONA Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Arvinas logo
ArvinasARVN
$600K-77.8%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$2.6M-373%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$1.06M+246%
Immunome logo
ImmunomeIMNM
$5.1M+199%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
-$288.89K-302%
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's increase (decrease) in prepaid expense and other assets?
LONA (LONA) reported increase (decrease) in prepaid expense and other assets of $396K in Q1 2026.
How has LONA's increase (decrease) in prepaid expense and other assets changed year-over-year?
LONA's increase (decrease) in prepaid expense and other assets increased by 212.2% year-over-year, from -$353K to $396K.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.